Braidwell »

Research Alliance Corp Iii shares owned by Braidwell

Quarter-by-quarter ownership of Research Alliance Corp Iii shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Research Alliance Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Research Alliance Corp Iii held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Research Alliance Corp Iii by Braidwell

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3M 400k 10.70

More positions owned by Braidwell

Caris Life Sciences (CAI)
Hinge Health Cl A (HNGE)
Glaukos (GKOS)
Edgewise Therapeutics (EWTX)
Spyre Therapeutics Com New (SYRE)
Irhythm Technologies (IRTC)
Neogenomics Com New (NEO)
Kodiak Sciences (KOD)
Xenon Pharmaceuticals (XENE)
Alphatec Hldgs Note 0.750% 3/1 (Principal)
Monte Rosa Therapeutics (GLUE)
Dianthus Therapeutics (DNTH)
Neurocrine Biosciences (NBIX)
Alphatec Hldgs Com New (ATEC)
Generate Biomedicines Com Shs (GENB)

View all positions for Braidwell

Top funds holding Research Alliance Corp Iii

Perceptive Advisors
ADAR1 Capital Management
BVF
Balyasny Asset Management
Spruce Street Capital
Trails Edge Capital Partners
TCG Crossover Management
Commodore Capital
Jupiter Topco
Braidwell
Cormorant Asset Management
Affinity Asset Advisors
Silverarc Capital Management
VR Adviser
J. Goldman & Co

View all funds holding Research Alliance Corp Iii